Sterol regulatory element binding (SRE) protein 2 (SREBP2) plays a canonical role in cholesterol homeostasis by its transcriptional regulation of molecules involved in cholesterol biosynthesis and low-density lipoprotein (LDL) uptake. 4 Cholesterol depletion leads to increased expression of SREBP2, along with its intronic microRNA-33 (miR-33), which replenishes cellular cholesterol by inducing genes that encode proteins such as HMG-CoA reductase and LDL receptor and suppressing the ATP-binding cassette transporter 1 (ABCA1). 5,6 Conversely, elevated levels of sterols suppress SREBP expression, thereby lowering cellular cholesterol levels. This homeostasis might be disrupted by atheroprone flow patterns, which induce sustained activation of SREBP1 and perturbation of EC function. 7
A therosclerosis preferentially develops at branches and curvatures in the arterial tree. Cardiovascular risk factors such as hyperlipidemia, smoking, and hypertension increase the prevalence and severity of lesions in these atheroprone regions. 1 At the cellular and molecular levels, disturbed flow patterns with low shear stress such as those found at vascular branches and curvatures increase the expression of genes such as interleukin 1β (IL-1β) and NADPH oxidase (NOX) to promote inflammatory and oxidative stresses in vascular endothelial cells (ECs). 2, 3 Such hemodynamic-induced functionally disturbed endothelium predisposes localized areas to become atherogenic, with ensuing monocyte recruitment and foam cell formation. Although extensive studies have revealed EC gene expression profiles associated with the atheroprone flow patterns, the key molecular events linking mechanical stimuli to atherogenic responses remain undetermined.
The connection between hemodynamic-induced endothelial dysfunction and inflammatory and oxidative stresses is poorly understood. However, aberrant lipid metabolism, unbalanced redox states, and innate immunity in phagocytes are linked through NLRP3 inflammasome with subsequent cleavage and activation of interleukin (IL)-1 family proteins. 8 Moreover, cholesterol crystals activate the NLRP3 inflammasome and increase the secretion of mature IL-1β in monocyte/macrophages. 9,10 LDL receptor-deficient mice receiving bone marrow-derived cells lacking NLRP3, ASC, or IL-1α/β were resistant to the development of diet-induced atherosclerosis. 9 Alone, systemic activation of NLRP3 inflammasome in macrophages does not explain the preferential localization of atherosclerosis in the arterial tree.
Disturbed flow can activate NOX and induce reactive oxygen species (ROS). 11 This raises the possibility that inflammasome is involved in oxidative stress in ECs. Additionally, a recent report of minute cholesterol crystals appearing early in atherosclerotic lesions 9 suggests a linkage between hemodynamic stimuli, SREBP2 activation, and NLRP3 inflammasome in ECs, all linked to atherosclerosis. Using in vitro and in vivo approaches, we report here that the atheroprone flowinduced endothelial inflammation and oxidative stress are mediated through SREBP2-elicited NLRP3 inflammasome. Our findings reinforce a primary role of EC innate immunity in the origin of atherosclerosis.
Methods

Antibodies and Reagents
Anti-SREBP2 antibody was from BD Transduction Laboratory and Abcam; anti-IL-1β, anti-caspase-1, and anti-α-tubulin, horseradish peroxide-conjugated anti-rabbit and anti-mouse antibodies were from Cell Signaling Technology; anti-ABCG1, anti-NLRP3, anti-NOX2 antibodies were from Abcam; anti-ABCA1 antibody was from Millipore; and anti-ASC antibody was from Enzo Life Science. The caspase-1 inhibitor Z-YVAD-FMK was from Biovision. 25-Hydroxycholesterol (25-HC) and methyl-β-cyclodextrin were from Sigma.
Cell Culture
Human umbilical vein ECs (HUVECs) were cultured in medium M199 (Gibco) supplemented with 15% FBS (Omega), 3 ng/mL β-EC growth factor, 4 U/mL heparin, and 100 U/mL penicillin-streptomycin. Total cholesterol was measured with the Infinity Total Cholesterol Kit (Thermo Scientific). Caspase-1 activity was measured with the use of the Caspase-1/ICE Colorimetric Assay Kit (R&D Systems). Primary mouse lung ECs were isolated as described. 12 
Shear Stress Experiments
A circulating flow system was used to impose shear stress on confluent monolayers of cells seeded on glass slides as described. 13 A reciprocating syringe pump connected to the circulating system introduced a sinusoidal (1 Hz) component onto the shear stress. The atheroprotective pulsatile shear flow (PS) or atheroprone oscillatory shear flow (OS) generated shear stresses of 12±4 or 1±4 dynes/cm 2 , respectively. The flow system was enclosed in a chamber held at 37°C and ventilated with 95% humidified air plus 5% CO 2 .
siRNA Knockdown
HUVECs at 50% to 70% confluence were transfected with SREBP2 siRNA, NLRP3 siRNA, ASC siRNA, NOX2 siRNA, or control siRNA at 20 nmol/L with Lipofectamine 2000 RNAi Max (Invitrogen). Experiments were performed with these cells at 48 hours after transfection.
Adenovirus Construction and Infection
Recombinant adenovirus encoding the mature form of SREBP2, that is, Ad-HA-SREBP2(N), was created, amplified, and titrated as reported previously. 14 For adenovirus infection, the virus mixture was added to 70% confluent cultured HUVECs and incubated for 12 hours. Adenovirus (Ad)-null was an infection control. The infected cells were then incubated in fresh growth medium for 24 hours before RNA or protein extraction.
Binding Site Prediction
The potential SREBP2 binding sites on selected human and mouse genes were predicted by use of the position weight matrix algorithm from TRANSFAC 15 to scan the promoter regions of the genes. The promoter regions were defined as −3000 to 500 from the transcriptional start site of the gene.
Chromatin Immunoprecipitation Assay
Chromatin immunoprecipitation assays were performed with standard protocols 16 using antibodies for SREBP2 (BD Transduction Laboratory) and mouse IgG (Cell Signaling).
EC-SREBP2(N) Transgenic Mice
Animal experimental protocols were approved by the Institutional Animal Care and Use Committee of the University of California, Riverside. The creation of the EC-SREBP2(N)-Tg mouse model is described in the online-only Data Supplement. Littermates carrying ApoE −/− or EC-SREBP2(N) +/+ ApoE −/− genotypes were generated by crossing EC-SREBP2(N)-Tg mice and ApoE −/− mice. All mice were housed in colony cages with a 14-hour light/10hour dark cycle and fed Rodent Diet 5001 (PMI Nutrition International) ad libitum unless otherwise indicated. Eightweek-old male EC-SREBP2(N) +/+ ApoE −/− mice and their male EC-SREBP2(N) −/− ApoE −/− littermates were fed a high-fat, highcholesterol diet containing 15% fat, 1.25% cholesterol, and 0.5% sodium cholate (Harlan Teklad) ad libitum. Eight weeks after the diet treatment, all mice were euthanized. In addition, 24-week-old male EC-SREBP2(N) +/+ ApoE −/− mice and their male EC-SREBP2 (N) −/− ApoE −/− littermates were fed normal chow. Mouse aortas were isolated to assess the extent and distribution of lesions by Oil Red O staining. 17 Lesion area was measured with Image Pro Plus 6.0 (Media Cybernetics) and expressed as a percentage of the total area of aorta. Plasma levels of total cholesterol, high-density lipoprotein cholesterol, and triglycerides were determined with assay kits from Wako Pure Chemicals (Tokyo, Japan).
Statistical Analysis
Data are expressed as mean±SEM (n=3 unless otherwise noted). In parametric data, the Student t test or ANOVA was used to analyze the differences among groups if data were determined to be normally distributed. For nonparametric data, the Mann-Whitney U test with the exact method was used to analyze differences between 2 groups. Values of P<0.05 were considered statistically significant.
Results
Coinduction of SREBP2 and miR-33 in ECs by OS
Initially, we examined the effects of PS and OS on the expression of SREBP2 in ECs. Imposition of OS, but not PS, activated SREBP2, as evidenced by the increased level of the mature form of SREBP2, namely SREBP2(N), and SREBP2 mRNA ( Figure 1A and 1B). Given that miR-33 is intronic with SREBP-2, OS also elevated the level of miR-33 ( Figure 1B) . Additionally, the expression of SREBP2-targeted genes, that is, HMG-CoA reductase, HMG-CoA synthase, squalene synthase, and LDL receptor, was higher with OS by guest on July 26, 2017 http://circ.ahajournals.org/ Downloaded from than PS ( Figure 1C ). The miR-33-targeted ABCA1, but not ABCG1, was downregulated at both the transcriptional and translational levels ( Figure 1D and 1E). Thus, OS increased the expression of genes involved in cholesterol synthesis and uptake while decreasing ABCA1, which is involved in cholesterol efflux. In line with these changes, the cholesterol content of HUVECs was greater with OS than PS ( Figure 1F ). One possible mechanism for OS induction of SREBP2 is that the action of OS is secondary to sterol depletion. Consequently, we examined whether sterol replenishment with 25-HC blocks the effect of OS on SREBP2 activation. Although 25-HC and methyl-β-cyclodextrin reduced and increased SREBP activation in HUVECs, respectively, incubation of 25-HC had little effect on OS-induced SREBP2 expression ( Figure 1G ). Interestingly, overexpression of the mature form of SREBP2, that is, SREBP2(N) or premiR33, increased the cholesterol content ( Figure IA and IB in the online-only Data Supplement. However, siRNA knockdown of SREBP2, but not miR-33, abolished OS-induced cholesterol accumulation ( Figure IC and ID in the online-only Data Supplement). Consequently, we focused on the role of SREBP2 in OS-disturbed endothelial functions.
OS Induces NLRP3 Inflammasome in ECs via SREBP2
The atheroprone nature of OS is due largely to its imposition of inflammatory and oxidative stresses on ECs. 18 Because SREBP1a induces caspase-1-activated NLRP3 inflammasome in macrophages, resulting in cleavage and secretion of IL-1 family cytokines, 19 we investigated whether OS induces inflammasome in ECs. The levels of cleaved caspase-1 and IL-1β were greater in ECs with OS than PS (Figure 2A ). Because OS induced SREBP2 maturation, we explored whether SREBP2(N) overexpression mimics OS to induce inflammasome in ECs. As expected, increased cleavage of caspase-1 and IL-1β was found in ECs infected with Ad-SREBP2(N) encoding SREBP2(N) ( Figure 2B ). Consistent with this finding, ectopic expression of SREBP2(N) increased caspase-1 activity in ECs ( Figure 2C ). With siRNA knockdown of endogenous SREBP2, OS-induced cleavage of caspase-1 or IL-1β was reduced ( Figure 2D ). Similar results were found when the inflammasome components NLRP3 and ASC were knocked down ( Figure 2E and 2F). Together, these results suggest that SREBP2 mediates OS-induced NLRP3 inflammasome in ECs. 
25-HC
SREBP2 Upregulates NOX2 With Increased ROS Production
We then investigated the underlying mechanism by which SREBP2 regulates the OS-induced inflammasome in ECs. The ROS level is increased by NLRP3 activators such as asbestos and silica, 20 and increased ROS are secondary messengers essential for inducing NLRP3 inflammasome. 20, 21 Given that OS is known to increase ROS production, 22 we examined SREBP2 augmentation in relation to ROS production. The intracellular level of ROS increased in ECs infected with Ad-SREBP2(N) encoding the mature form of SREBP2 ( Figure 3A ). To assess the source of the increased level of ROS in ECs overexpressing SREBP2(N), we monitored ROS-generating mitochondria using MitoSOX, a selective mitochondrial superoxide indicator. Rotenone, the complex I inhibitor, greatly increased mitochondrial ROS production, but Ad-SREBP2(N) overexpression was without effect ( Figure 3B ). Therefore, the increased ROS production caused by SREBP2 activation probably did not originate from mitochondria. Bioinformatics predicted the presence of 3 SREs in the promoter region of the human NOX2 gene (−2381/−2367, −867/−861, and −674/668 bp; Figure 3C ). Consistent with this prediction, the levels of NOX2 mRNA and protein increased in Ad-SREBP2(N)-infected HUVECs and in ECs isolated from transgenic mice overexpressing SREBP2(N) in endothelium [EC-SREBP2(N)-Tg] ( Figure 3D-3F ). Of note, the levels of other NADPH oxidase subunits (except NOX1) were not significantly increased in these cells ( Figure  II in the online-only Data Supplement). Chromatin immunoprecipitation assay demonstrated an increase in the binding of SREBP2 to the 3 SREs containing the consensus sequence of CACC(T)CCA ( Figure 3G ). To investigate whether SREBP2 is required for OS-induced NOX2, we knocked down SREBP2 and found that the OS-induced NOX2 was partially suppressed ( Figure 3H ). Furthermore, NOX2 knockdown inhibited the OS-induced caspase-1 and IL-1β cleavage ( Figure 3I ). A similar inhibitory effect was found in NOX2 −/− mouse embryonic fibroblasts ( Figure III in the online-only Data Supplement). These results suggest that the SREBP2-transactivated NOX2 is required for OS-induced inflammasome in ECs.
SREBP2 Upregulates NLRP3 Expression
Bioinformatics also predicted the presence of an SRE located at −1379/−1368 bp in the promoter region of the NLRP3 gene ( Figure 4A ). As expected, NLRP3 expression was increased in Ad-SREBP2(N)-infected HUVECs ( Figure 4B and 4C) and ECs isolated from EC-SREBP2(N)-Tg mice ( Figure 4D ). Chromatin immunoprecipitation assays demonstrated an increase in the binding of SREBP2 to SRE containing the consensus sequence CCGCCACCACAC ( Figure 4E ). To investigate whether SREBP2 is required for OS-induced NLRP3 expression, we knocked down SREBP2. Accordingly, the level of NLRP3 responding to OS was decreased ( Figure 4F ).
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Caspase D, Representative immunoblot of procaspase-1, caspase-1 p20, pro-IL-1β, IL-1β p17, SREBP2 precursor, and mature form of SREBP2 in HUVECs transfected with 20 nmol/L control RNA or SREBP2 siRNA for 48 hours and then exposed to static conditions or OS for 14 hours. E, Representative immunoblot for procaspase-1, caspase-1 p20, pro-IL-1β, IL-1β p17, and NLPR3 in HUVECs transfected with 20 nmol/L control RNA or NLRP3 siRNA for 48 hours and then exposed to static conditions or OS for 14 hours. F, Representative immunoblot of procaspase-1, caspase-1 p20, pro-IL-1β, IL-1β p17, and ASC in HUVECs transfected with 20 nmol/L control RNA or ASC siRNA for 48 hours and then exposed to static conditions or OS for 14 hours. by guest on July 26, 2017 http://circ.ahajournals.org/ Downloaded from August 6, 2013 Therefore, the OS-activated SREBP2 transactivates NLRP3 in ECs.
SREBP2(N) Overexpression Enhances Endothelial Inflammation
IL-1β stimulates the expression of chemokines, for example, monocyte chemoattractant protein 1, and adhesion molecules, for example, vascular cell adhesion molecule 1 and E-selectin, in ECs, which enhances leukocyte-endothelium interactions. In agreement with increased IL-1β secretion via SREBP2augmented inflammasome, SREBP2(N) overexpression increased the mRNA levels of monocyte chemoattractant protein 1, vascular cell adhesion molecule 1, and E-selectin ( Figure 5A ). Increased expression of monocyte chemoattractant protein 1 and adhesion molecules was also found in ECs isolated from EC-SREBP2(N)-Tg mice compared with wild-type littermates ( Figure 5B ). The SREBP2(N)-induced inflammation in ECs was associated with increased monocyte association, which was attenuated with caspase-1 inhibitor or NOX2 or NLPR3 siRNA knockdown ( Figure 5C and 5D). Thus, NLRP3 inflammasome induced by OS via SREBP2 is functionally linked to endothelial proinflammatory responses.
SREBP2-NOX2-Inflammasome Activation in Atheroprone Regions of the Mouse Aorta
We next investigated whether the differential regulation of SREBP2 by PS and OS in ECs cultured in the flow channel also translated to a functional or functionally disturbed endothelium in atheroprotective versus atheroprone regions in the mouse arterial tree. As shown in Figure 6A and 6B, the activation of NLRP3 inflammasome was evident in the aortic arch, where the endothelium is exposed predominantly to disturbed flow. 23 As expected, the levels of the cleaved caspase-1 and IL-1β, that is, IL-1β p17, were higher in the aortic arch than in the thoracic aorta ( Figure 6B ). Consistent with this observation, the expression of IL-1β-regulated genes, that is, Figure 6A ). In addition, we separated intima (endothelium) from media and adventitia of thoracic aorta and aortic arch of C57BL/6 mice. As illustrated in Figure 6C , the expression levels of SREBP2, NOX2, and NLRP3 in the isolated endothelium in aortic arch were higher than those in thoracic aorta. Importantly, no differences were found between thoracic aorta and aortic arch in tissues containing media and adventitia. Higher levels of NLRP3, NOX2, and SREBP2 in the aortic arch were also verified by in situ hybridization ( Figure IV in the online-only Data Supplement). Thus, the NLPR3 inflammasome is activated in the endothelium of atheroprone region of the arterial tree in vivo. EC-specific SREBP2(N) overexpression mimicking OS induction of SREBP2 should render the thoracic aorta of EC-SREBP2(N)-Tg mice atheroprone. As expected, activation of NLRP3 inflammasome and induction of chemoattractants and adhesion molecules were seen in these arterial segments compared with corresponding areas in wild-type littermates ( Figure 6D 
SREBP2(N) Overexpression in ECs Predisposes Atherosclerosis
We introduced the ApoE-null background into EC-SREBP2(N)-Tg mice to investigate whether EC-specific overexpression of SREBP2(N) leads to atherogenesis in atheroprotective regions in ApoE −/− /EC-SREBP2(N) mice. After 8 weeks of an atherogenic diet, the levels of total cholesterol and LDL were comparable between ApoE −/− /EC-SREBP2(N) mice and their ApoE −/− littermates (Table 1 ). However, the mean lesion area in thoracic aortas was ≈1.5-fold larger for ApoE −/− /EC-SREBP2(N)-Tg than ApoE −/− mice (17.4±1.7% versus 11.5±1.3%; Figure 7A and 7C). The mean lesion area in the aortic arch was also larger for ApoE −/− /EC-SREBP2(N) than ApoE −/− mice (47.7±2.5% versus 39.7±3.1%). The order of lesion size was as follows: aortic arch of ApoE −/− / EC-SREBP2(N) mice>aortic arch of ApoE −/− mice>thoracic aorta of ApoE −/− /EC-SREBP2(N) mice>thoracic aorta of ApoE −/− mice. The total lesion area as a sum of aortic arch, thoracic aorta, plus abdominal aorta remained greater for ApoE −/− /EC-SREBP2(N) mice than control littermates (22.5±1.4% versus 18.2±1.5%). These results demonstrate that local flow patterns synergize with other atherogenic factors, for example, hyperlipidemia, in the formation of atherosclerotic lesions. We also compared the lesion development in the 2 groups of animals fed normal chow for 24 weeks. As expected, the serum levels of total cholesterol and LDL were significantly lower with normal chow than with an atherogenic diet (Table 1) . Compared with the ApoE −/− littermates, ApoE −/− /EC-SREBP2(N) mice showed more lesions in aortic arches, particularly the inner curvature of the arch and the orifices of the arch vessels ( Figure 7B and 7D). Previous studies by others showed that these areas have elevated nuclear factor-κB and vascular cell adhesion molecule 1 activation. 23, 24 Of note, with normal chow, lesion areas were marginal in the thoracic aortas of both ApoE −/− /EC-SREBP2(N) and ApoE −/− mice, which reiterates the notion that hyperlipidemia synergizes with hemodynamic forces in the origin of atherosclerosis.
Discussion
The "response-to-injury" hypothesis states that endothelial dysfunction precedes the development of atherosclerosis. 25 Much evidence suggests that atheroprone flow patterns in the conduit arteries are a determining factor of atherogenesis. Furthermore, the Pathological Determinants of Atherosclerosis in Youth (PDAY) study provides unequivocal evidence that cardiovascular risk factors (eg, hyperlipidemia, smoking, and hypertension) exacerbate atherosclerosis in atheroprone areas in the human arterial tree. 26, 27 Here, we report that disturbed flow applied to ECs induced NLRP3 inflammasome via SREBP2 activation. Such SREBP2 activation of NLRP3 inflammasome is sufficient for functionally disturbed endothelium leading to atherogenesis as supported by mouse models harboring the EC-SREBP2(N) transgene. Differential development of atherosclerotic lesions in the aortic arch compared with thoracic aorta in mice with or without EC-specific expression of SREBP2(N) and in the presence or absence of an atherogenic diet ( Figure 7) provides a molecular basis for the hemodynamic-induced atherosclerosis susceptibility seen in the human arterial tree. We reasoned that endothelial expression of SREBP2(N) mimicking the effect of disturbed flow synergizes with hyperlipidemia (caused by an ApoE −/− background together with an atherogenic diet) to accelerate atherosclerosis. The thesis is further supported by experiments using EC-SREBP2(N)-Tg or wild-type C57BL6 mice fed an atherogenic diet. Early atherosclerotic plaques developed in the aortic root of EC-SREBP2(N)-Tg mice but not control littermate mice ( Figure VI in the online-only Data Supplement and Table 2 ). Thus, the translational relevance of this study is that the spatial localization and severity of atherosclerosis can depend on atheroprone flow coupled with cardiovascular risk factors via SREBP2(N)-induced NLRP3 inflammasome. Clearly, IL-1β is a major atheroprone factor. 28 Atherosclerosis was decreased in several rodent models lacking IL-1β or type I IL-1 receptor. 29, 30 In contrast, mice deficient in IL-1 receptor antagonist show increased atherosclerosis. 31 Canakinumab, an anti-human IL-1β monoclonal antibody, is currently being used in the Canakinumab 
Anti-inflammatory Thrombosis Outcomes Study (CANTOS)
to assess the efficacy of anti-IL-1β in reducing cardiovascular events. 32 The antiatherosclerosis effect resulting from IL-1β antagonism should involve the inhibition of NLRP3 inflammasome in the endothelium and should be experimentally verified. Undoubtedly, NLRP3 inflammasome in monocyte/ macrophage is important for atherosclerosis, as suggested by transplantation experiments with bone marrow deficient in NLRP3, ASC, or IL-1α/β. 9 However, this macrophage-associated mechanism would not contribute to functionally disturbed endothelium and ensuing atherosclerosis in our mouse models because the SREBP2(N) transgene was expressed only in ECs, not in bone marrow-derived macrophages ( Figure VII Reconciling published literature with the present report, we propose that the disturbed flow-increased NLRP3 inflammasome in ECs and consequent production and secretion of IL-1β create a focal gradient of inflammatory cytokines and chemoattractants. This flow-elicited proinflammatory milieu recruits sentinel cells (ie, monocytes) and facilitates the retention and differentiation of monocytes in the subendothelial space. Indeed, atherosclerosis was found to be substantially lower in ApoE −/− /IL-1β −/− than ApoE −/− /IL-1β +/+ thoracic aortas. 30 In macrophages, the SREBP2-coinduced miR-33a targets ABCA1, which impairs reverse cholesterol transport. 5, 6 An antigomir against miR-33 decreases atherosclerosis in LDL receptor-null mice, with a concomitant increase in the level of high-density lipoprotein. 33 Inhibition of miR-33 also increases the level of high-density lipoprotein and lowers that of very LDL triglycerides in nonhuman primates. 34 In line with SREBP2 induction, OS-induced miR-33a targets ABCA1 in ECs (Figure 1) . Given that cholesterol crystals are an inflammasome inducer, 9 disturbed flow patterns should increase the cholesterol level, which arguably synergizes with SREBP2 to activate NLPR3 inflammasome. Conversely, the atheroprotective flow patterns should induce liver X receptors and hence upregulate ABCA1 to facilitate reverse cholesterol transport. 35 Civelek et al 36 reported no site-specific differences in endothelial ABCA1 expression between susceptible and protected sites of swine arteries. However, our published work showed that ABCA1 level is lower in the mouse aortic arch compared with thoracic aorta. 35 The possible reason for the discrepancy is the different species and diets used in the 2 studies. Given that hypercholesterolemia significantly increased ABCA1 expression in swine endothelium, it might be difficult to detect a site-specific difference in endothelial ABCA1 expression.
Table 1. Serum Lipid Profile of ApoE −/− /EC-SREBP2(N) and Their ApoE −/− Littermates Fed a Normal Chow or an Atherogenic Diet
The intracellular and extracellular levels of sterols intricately regulate SREBP2, which in turn modulates cellular cholesterol homeostasis. 4 Significantly, excessive amounts of 25-HC do not prevent OS induction of SREBP2 ( Figure 1G ), suggesting that the mechanotransduction mechanism overrides that of the cholesterol-sensing system, leading to sustained SREBP2 activation. Thus, the disturbed flow-activated SREBP2 appears to disrupt cholesterol homeostasis in its activation of inflammasome. This argument can explain the synergism between atheroprone flow and hyperlipidemia in inducing atherosclerosis.
The endoplasmic reticulum stress/unfolded protein response is activated in ECs by atheroprone flow in vitro 37 and is upregulated in endothelium of swine atheroprone sites in vivo. 38 We have Figure 1A) . Support for the 2 distinct mechanisms of SREBP2 regulation comes from experiments showing that ATF6 and SREBP2 were coinduced in ECs under OS and that ATF6 knockdown by siRNA did not affect SREBP2 induction by OS (data not shown).
Among mechanosensitive signaling molecules, Akt and adenosine monophosphate-activated protein kinase regulate the endothelial phenotypic changes responding to atheroprone and atheroprotective flow, respectively. 39 Akt positively regulates SREBP 40 through direct phosphorylation and transcriptional activation via mTORC1. On the other hand, adenosine monophosphate-activated protein kinase inhibits SREBP-1c and -2 activities through Ser372 phosphorylation, which inhibits SREBP cleavage, nuclear translocation, and transcriptional activity. 41 Thus, the disturbed flow-activated Akt is likely involved in SREBP2 activation in atheroprone areas, whereas SREBP2 suppression in atheroresistant areas is mediated at least in part by adenosine monophosphate-activated protein kinase. Thus, adenosine monophosphate-activated protein kinase activators such as statin and metformin may play a beneficial role similar to that of atheroprotective flow in phosphorylating SREBP2.
SREBP-1a is involved in the lipopolysaccharide-stimulated IL-1β production through activation of NLRP1a inflammasome in macrophages. 19 The SREBP1 promoter region also contains an SRE binding site, which can be regulated by SREBP2. 42 The OS-induced SREBP2 should also activate SREBP1 because ECs transfected with Ad-SREBP2(N) showed an increased expression of SREBP1 ( Figure VIII in the online-only Data Supplement). However, we did not find increased levels of NLRP1a in ECs from EC-SREBP2(N)-Tg mice ( Figure VIII in the online-only Data Supplement). Most, if not all, NLRP3 activators upregulate NOXs, with concurrent elevation of the short-lived ROS, so NOX-mediated redox signaling is involved in NLRP3 inflammasome activation. 20, 21 Nevertheless, NOXs are not necessary for inflammasome activation in hematopoietic cells because immune cells deficient in NOXs show normal or hyperactive activation of inflammasome. 43, 44 In contrast, our data in Figure 3 suggest that SREBP2 transactivation of NOX2 is necessary for inducing NLRP3 inflammasome in ECs. Although the molecular basis of the discrepancies between macrophages and ECs remains unknown, SREBP2 induction of NOX2 is implicated in endothelial biology in that the major enzymatic product of NOX2 is ROS. 45 As summarized in Figure 8 , we demonstrated that atheroprone flow, like endogenous damage-and pathogen-associated molecules such as cholesterol crystals and lipopolysaccharide, induces NLRP3 inflammasome in endothelium via SREBP2 activation. This increased innate immunity in endothelium synergizes with hyperlipidemia to result in the focal nature of atherosclerosis. 
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SUPPLEMENTAL MATERIALS
Supplemental methods
Isolation of Primary Mouse Lung Endothelial Cells
Isolation of primary mouse lung endothelial cells were performed as described previously 1 . Monoclonal rat anti-mouse CD31 antibody from BD Transduction Laboratory was covalently coupled to pre-washed Dynabeads® sheep anti-rat IgG during an overnight incubation. Lung tissue was excised, aseptically minced into 1 mm x 2 mm squares, digested with collagenase A at 37 ºC with gentle agitation for 45 min, triturated 12 times with a 30-cc syringe, and passed through a 70-µm disposable cell strainer (BD Falcon) into a 50 mL conical centrifuge tube. The cell suspension was then centrifuged at 400 × g for 8 min at 4 °C, and the pellet was resuspended in 2 mL of medium. Anti-CD31 coated beads were added to the cell suspension, mixed, and incubated for 10 min at room temperature. The bead-bound cells were isolated with a magnet, resuspended in growth medium M199, and plated on collagen-coated T75 flasks. At the following day, the flasks were washed with media to remove loosely adherent cells.
Immunoblotting
Cells or tissue samples were lysed with a buffer containing 10 mM Tris, pH 7.4, 100 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM NaF, 20 mM Na4P2O7, 2 mM Na3VO4, 0.1% sodium dodecylsulfate, 0.5% sodium deoxycholate, 1% Triton X-100, 10% glycerol, 10 mg/ml leupeptin, 60 mg/ml aprotinin, and 1 mM phenylmethanesulfonyl fluoride (PMSF).
The extracted proteins were resolved by using either a 8% or 15% SDS-PAGE gel, followed by transfer to a polyvinylidene difluoride membrane (Bio-Rad) prior to immunoblotting.
Real-time PCR
Total RNA was isolated with use of TRIzol reagent (Invitrogen). Quantitative real-time PCR (qRT-PCR) with the TaqMan miRNA assay kit (Applied Biosystems) was used to measure the level of miR-33. The quantitative PCR (qPCR) was performed with an iQ SYBR Green Supermix (Bio-Rad) using iCycler Real-time PCR Detection System (Bio-Rad).
The primer sequences are in the Supplemental Table section .
Primer Sequences Used in CHIP assay
Primers used for detection of the binding of SREBP2 to the three SREBP2 binding sites (SRE1, SRE2, SRE3) in the human NOX2 promoter were as follows: forward sequence (SRE1) 5'-TTGCCTGGAAACATGATTGCCA-3' , and the reverse sequence 
Measurement of ROS Production
After adenovirus infection, cells were exposed to 10 µM cell-permeable 2',7'-dichlorodihydrofluorescein diacetate (H2DCFDA) (Invitrogen), and ROS fluorescence
was measured with use of a Perkin Elmer Victor 2 1420 multi-label counter at 485-nm excitation and 535-nm emission. MitoSOX (Molecular Probes) was used as a live cell-permeable and mitochondrial localizing superoxide indicator. After adenovirus infection, cells were exposed to 2.5 µM MitoSOX for 30 min at 37 °C. Fluorescence intensity was measured using BD Biosciences FACSCanto II flow cytometer. For each analysis, 10,000 events were recorded. The data was analyzed using FCS Express analysis software (De Novo Software).
EC-SREBP2(N) Transgenic Mice
The SacI/BamHI fragment of HA-SREBP2(N) from pCMV5-HA-SREBP2(N) 2 was inserted into the EcoRV site of a pBluescriptIIKS vector containing an SV40 polyA signal.
The SalI/XhoI fragment of the vascular endothelial-cadherin (VE-cadherin) promoter was then subcloned into the SalI site of the above-mentioned construct to yield pKSIICAD-BP2N2pA. The transgene was released by SalI/NotI double digestion followed by purification. Fertilized embryos from the hybrid strain CB6, an F1 hybrid between a BalbC and C57BL/6J mouse, were microinjected with the transgene at the UCSD transgenic mouse core facility. DNA from tails of the offspring was isolated and subjected to polymerase chain reaction (PCR). Mice with high levels of transgene incorporation were crossbred with C57BL/6J mice for two additional generations.
Vasodilatation Assay
The 
Endothelial Monocyte Adhesion Assay
Monocyte adhesion to HUVEC monolayers was determined by using a CytoSelect Adhesion Assay Kit (Cell Biolabs). HUVECs were transfected with control siRNA, NOX2 siRNA, or NLRP3 siRNA, then infected with Ad-SREBP2(N) or Ad-null for 24 hr. The infected cells were also treated with or without caspase-1 inhibitor Z-YVAD-FMK (2 µM) for 24 hr. THP1 monocytes (1 × 10 5 cells/well) were labeled with LeukoTracker and incubated for 30 min at 37 °C. To quantify monocyte adhesion, a Perkin Elmer Victor 2 1420 multi-label counter was used to measure fluorescence of lysed cells at 480-nm excitation and 520-nm emission.
Histology
The whole hearts were harvested, fixed in 4% paraformaldehyde in PBS overnight and, stepwise, dehydrated in 30%, 50%, 70%, 90% and 100% ethanol, each for 30 min. Tissues were subsequently incubated in xylene for 30 min at room temperature and embedded in paraffin at 55 °C. Five-µm cross sections were prepared and stained with Hematoxylin and eosin.
En face immunostaining
Mouse aortas were fixed and excised for determination of SREBP2, NOX2 and NLRP3 Supplemental Table   Table S1 
